Abstract
The cytochalasin B (CYB)-blocked binucleated cell assay has been explored to analyze munuclei and cell cycle kinetics using 2 known mutagenic carcinogens in V79 Chinese hamster lung cells. To determine the optimum time to obtain the maximum number of binucleated cells for munucleus analysis, duplicate cultures of exponentially growing cells were treated with 3 μg/ml CYB for varying durations (8–48 h). A peak appearance of binucleated cells at 16 h in the presence of CYB suggested this as an optimum time for munucleus analysis in binucleated V79 cells. To evaluate the capacity for induction of munuclei in V79 cells, 2 mutagenic carcinogens, mitomycin C (0.125–1.0 μg/ml) and cyclophosphamide (2–12 μg/ml) were tested in duplicate cultures. Mitomycin C, a direct-acting alkylating agent, caused approximately an 18-fold increase in munucleus frequency over controls at the highest concentration tested (1.0 μg/ml), and this increase occurred in a dose-related manner ( r = 0.92). The concentrations of mitomycin C tested also caused a significant dose-related cell cycle delay, thus suggesting cytotoxicity to V79 cells. Cyclophosphamide, an indirect-acting alkylating agent, requiring the presence of S9 mix, caused approximately a 17-fold increase in munucleus frequency over controls at the highest tested concentration (12 μg/ml), with a clear dose response ( r = 0.99). The various concentrations of cyclophosphamide also caused cytotoxicity in a dose-related fashion. Thus, this study demonstrates the usefulness of the cytokinesis-block method in V79 cells as a possible screen to analyze munucleus induction and cytotoxicity. Because this approach is much less labor intensive than conducting a structural chromosomal analysis, this assay has great potential both as an initial screen for clastogenic activity and as a tool for investigating the underlying mechanisms for clastogenicity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
